16
Participants
Start Date
October 17, 2011
Primary Completion Date
August 15, 2018
Study Completion Date
August 15, 2018
Cetuximab
First dose of 400 mg/m\^2 by vein on Days 1 and 8 over 2 hours, second dose of 250 mg/m\^2 on week 2 and 3 (if applicable) given over 1 hour.
IMC-A12
6 mg/kg/week by vein on Days 1 and 8 over 1 hour on weeks 1 and 2 and 3 (if applicable).
Surgical tumor resection
Surgical tumor resection on Day 10.
University of Texas MD Anderson Cancer Center, Houston
Eli Lilly and Company
INDUSTRY
M.D. Anderson Cancer Center
OTHER